|
ZNF239 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.253000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.558000E-01 |
| Normal-vs-Stage2 |
8.641400E-01 |
| Normal-vs-Stage3 |
5.305400E-01 |
| Normal-vs-Stage4 |
6.314000E-01 |
| Stage1-vs-Stage2 |
5.779600E-01 |
| Stage1-vs-Stage3 |
7.043200E-01 |
| Stage1-vs-Stage4 |
7.041600E-01 |
| Stage2-vs-Stage3 |
7.832200E-01 |
| Stage2-vs-Stage4 |
8.391400E-01 |
| Stage3-vs-Stage4 |
9.573000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.622600E-01 |
| Normal-vs-AfricanAmerican |
6.713000E-01 |
| Normal-vs-Asian |
6.047800E-04 |
| Caucasian-vs-AfricanAmerican |
9.435000E-01 |
| Caucasian-vs-Asian |
2.078400E-02 |
| AfricanAmerican-vs-Asian |
8.398400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.108000E-01 |
| Normal-vs-Female |
3.215800E-01 |
| Male-vs-Female |
7.850000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.129800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.893200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.411170E-01 |
| Normal-vs-Age(81-100Yrs) |
6.589000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.944820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.176200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.092800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.759900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.774600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.238000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.918600E-01 |
| Normal-vs-Grade 2 |
3.960800E-01 |
| Normal-vs-Grade 3 |
3.330800E-01 |
| Normal-vs-Grade 4 |
3.069800E-01 |
| Grade 1-vs-Grade 2 |
4.844000E-01 |
| Grade 1-vs-Grade 3 |
5.670800E-01 |
| Grade 1-vs-Grade 4 |
4.402200E-01 |
| Grade 2-vs-Grade 3 |
7.596000E-01 |
| Grade 2-vs-Grade 4 |
6.279600E-01 |
| Grade 3-vs-Grade 4 |
8.424200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.541000E-01 |
| Normal-vs-ccB subtype |
1.856210E-01 |
| ccA subtype-vs-ccB subtype |
3.168800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.277400E-01 |
| Normal-vs-N1 |
2.664800E-01 |
| N0-vs-N1 |
3.198800E-01 |
|
|
